Michael P. Bova

Pain Medicine

515 Ray C Hunt Dr Bldg 515
Charlottesville, VA 22903

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Answering the Rehabilitation 2030 Call.

Answering the Rehabilitation 2030 Call.

Journal: PM & R : the journal of injury, function, and rehabilitation

Published: December 05, 2023

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.

Novel Small Molecules Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein Protect Against Diverse α-Synuclein Mediated Dysfunctions.

Journal: Scientific reports

Published: May 01, 2019

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Journal: PloS one

Published: September 24, 2013

Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors.

Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors.

Journal: Biochemical and biophysical research communications

Published: September 03, 2013

Development of a novel β-secretase binding assay using the AlphaScreen platform.

Development of a novel β-secretase binding assay using the AlphaScreen platform.

Journal: Journal of biomolecular screening

Published: April 02, 2013

Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases.

Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases.

Journal: Nature communications

Published: December 13, 2012

Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.

Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: December 03, 2012

Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.

Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: December 03, 2012

Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target.

Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target.

Journal: PloS one

Published: November 21, 2012

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors.

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: November 19, 2012

Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.

Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.

Journal: Bioorganic & medicinal chemistry letters

Published: November 16, 2012

Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.

Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: October 03, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026